Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by HCallahann44on Aug 13, 2021 3:58pm
254 Views
Post# 33702213

Thanks West ---the Bull Case -Unoteable??

Thanks West ---the Bull Case -Unoteable??I wonder---I bought another 1000 shares today...but in this market momo always seems to prevail so sava may zoom to 3200 while we languish. Even though the stock drops every day I keep coming back to the following---- 1. Pela is SAFE ---product safety is what tanks most biotechs...our virus has passed that test. We had permission to move to Phase 3 but held off to ID biomarkers...which we have now done with some success. 2. It seems to work with every type of Immunotherapy --and one wonders just how well it would work if the test cases were not previously fried with radiation and chemo. 3. It can be administered by low level medical personnel...its systemic and finds the cancer---maybe the only onco virus that can be administered this way....though there may be one other...but its genetically engineered...I think its safer to stay away from the genetic tampering stuff... 4. We are partnering with a lot of big pharma....some on the yahoo board will write this off...saying ---nah they are just letting ONCY play with their meds. I doubt this is the case...given the risks and liability. These pharmas must have done a ton of DD before agreeing to these trials. 5. Every analyst that has looked at it...in a lot more detail than we have is projecting a price a min of 4x higher than today. 6. Making these other immunotherapy treatments just a fraction more effective translates into big $$$ for the pharmas. 7. Big pharma could pay what is a small amount of money to the pharma...but that could translate to a big pay day for us. 8. Other companies with products that don't appear as versatile as PELA are selling for 10x our current market cap. 8. All of this has to be balanced against a lack of insider buying...a lack of institutional buying...even by institutions whose analysts are saying the stock is a strong buy ----these factors are what keep me up!! And I wonder if the royalty payments are a factor holding back a sale? Does Matt care if he gets a good price for the company if most of his compensation is in the royalty side???
<< Previous
Bullboard Posts
Next >>